HDAC9 and lung adenocarcinoma: Gratifyingly, quantitative PCR indeed uncovered a notable reduction of NKX2-1 or SOX2 levels along with HDAC blockage in all tested lung adenocarcinoma or squamous cell carcinoma models, respectively (Figure 4—figure supplement 2A).